Abdulla A. Damluji, MD, PhD Profile picture
• I swam in Tigris River in the '90s. • Then, competitive swimmer • Now, physician-scientist (interventional cardiology) • @NYUStern EMBA'23 • Tweets are my own

Nov 5, 2021, 20 tweets

Cardiac Arrest and Cardiogenic Shock

There is a societal paper on this in the works too!

Very important work!

@Babar_Basir @venumenon10

#TCT2021 @TCTMD

Methylprednisone - ? not helpful

Advanced reperfusion strategies - small trial

#TCT2021

SCAI Shock Classification

Milrinone vs Dobutamine - no difference

Gaps in pressers in CICU setting: pressers and antiplatelets

@seanvandiepen @JasonKatzMD

#TCT2021

Invasive hemodynamics monitoring

MCS

Unloading

#TCT2021

Shock Teams - CICU @JACCJournals

3-axis model

HF readmission in shock pt

Excellent @Babar_Basir

#TCT2021

@SandeepNathanMD excellent session

***Multi-vessel PCI in Shock***

First side of the coin

Multivessel PCI should not be performed in shock ??

Culprit Shock: Culprit only

NNT = 12

@thiele_holger

#TCT2021

European guidelines

Long term outcomes

STEM pts?

Culprit lesion only PCI and followed by stage PCI in shock

Multivessel PCI in Shock is Way to Go

ESC Guidelines

CI cross in culprit cross at one year?

Metaanalysis - may be there is benefit?

But there is increased risk in renal failure

Culprit is open label - procedural differences?

@BillONeillMD

#TCT2021

NCSI -

77% improved outcomes with support

Culprit vs NCSI

#TCT2021

Conclusion - too nuanced to tell?

#TCT2021

Decisions to use what device in cardiogenic shock

@SandeepNathanMD

Trials and registry data

Impella vs balloon pump

Impella CP in AMI Shock?

#TCT2021

The Pro Case?

Impella CP as first line in shock

Goal in AMI Shock - improved supply/demand

Hemodynamic Effect of IABP, pLVAD, and ECMO

#TCT2021

IABP in AMI-CS

The longer patients linger? the more likely they die...@behnam_tehrani

#TCT2021

Impella Data

Reducing cardiac work

NCSI data @Babar_Basir

Shock teams in patients from the critical care cardiology network @ShashankSinhaMD

Escalation of Device Therapies

- ECMO + Impella (facilitating LV recovery?)

All good, but we need clinical trials in this space.

So far it is hard to argue with @SandeepNathanMD

Excellent session and great speakers @BinitaShahMD @NavinKapur4

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling